Healthcare provider profile · identity verified

Daniel B. Erlanger, D.O.

Internal Medicine · PITTSBURGH, PA · NPI 1396709945

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	567	157
Levothyroxine Sodium	Levothyroxine Sodium	399	81
Amlodipine Besylate	Amlodipine Besylate	281	75
Lisinopril	Lisinopril	256	62
Furosemide	Furosemide	244	63
Pantoprazole Sodium	Pantoprazole Sodium	236	59
Eliquis	Apixaban	218	49
Omeprazole	Omeprazole	202	57
Simvastatin	Simvastatin	191	41
Metoprolol Tartrate	Metoprolol Tartrate	179	40
Potassium Chloride	Potassium Chloride	177	39
Tamsulosin Hcl	Tamsulosin Hcl	160	39
Escitalopram Oxalate	Escitalopram Oxalate	154	42
Sertraline Hcl	Sertraline Hcl	131	25
Metformin Hcl	Metformin Hcl	130	33
Metoprolol Succinate	Metoprolol Succinate	125	31
Gabapentin	Gabapentin	121	32
Rosuvastatin Calcium	Rosuvastatin Calcium	117	30
Donepezil Hcl	Donepezil Hcl	114	20
Clopidogrel	Clopidogrel Bisulfate	104	28
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	94	22
Losartan Potassium	Losartan Potassium	92	24
Carvedilol	Carvedilol	90	28
Duloxetine Hcl	Duloxetine Hcl	89	21
Allopurinol	Allopurinol	83	12
Alendronate Sodium	Alendronate Sodium	75	21
Trazodone Hcl	Trazodone Hcl	73	20
Finasteride	Finasteride	69	15
Atenolol	Atenolol	65	11
Ezetimibe	Ezetimibe	63	12
Xarelto	Rivaroxaban	61	suppressed
Spironolactone	Spironolactone	59	18
Warfarin Sodium	Warfarin Sodium	57	12
Famotidine	Famotidine	56	12
Lorazepam	Lorazepam	56	17
Memantine Hcl	Memantine Hcl	55	14
Montelukast Sodium	Montelukast Sodium	55	suppressed
Buspirone Hcl	Buspirone Hcl	50	12
Citalopram Hbr	Citalopram Hydrobromide	50	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	48	12
Jardiance	Empagliflozin	47	13
Mirtazapine	Mirtazapine	47	13
Venlafaxine Hcl Er	Venlafaxine Hcl	46	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	45	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	44	13
Hydrochlorothiazide	Hydrochlorothiazide	43	11
Ropinirole Hcl	Ropinirole Hcl	41	suppressed
Valsartan	Valsartan	38	suppressed
Prednisone	Prednisone	37	23
Alprazolam	Alprazolam	36	16
Fluticasone Propionate	Fluticasone Propionate	36	14
Olanzapine	Olanzapine	36	suppressed
Repaglinide	Repaglinide	35	suppressed
Bupropion Xl	Bupropion Hcl	33	suppressed
Pravastatin Sodium	Pravastatin Sodium	32	11
Carbidopa-Levodopa	Carbidopa/Levodopa	30	suppressed
Risperidone	Risperidone	30	suppressed
Synthroid	Levothyroxine Sodium	30	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	29	suppressed
Ranolazine Er	Ranolazine	28	suppressed
Tramadol Hcl	Tramadol Hcl	28	14
Zolpidem Tartrate	Zolpidem Tartrate	28	11
Ondansetron Hcl	Ondansetron Hcl	27	19
Enalapril Maleate	Enalapril Maleate	26	suppressed
Humalog Kwikpen U-100	Insulin Lispro	26	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Oxycodone Hcl	Oxycodone Hcl	24	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	23	suppressed
Sucralfate	Sucralfate	23	suppressed
Bumetanide	Bumetanide	21	suppressed
Digoxin	Digoxin	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	13
Irbesartan	Irbesartan	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Matzim La	Diltiazem Hcl	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Baclofen	Baclofen	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	19	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Timolol Maleate	Timolol Maleate	18	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	17	suppressed
Cefuroxime	Cefuroxime Axetil	17	17
Chlorthalidone	Chlorthalidone	17	suppressed
Morphine Sulfate Er	Morphine Sulfate	17	suppressed
Telmisartan	Telmisartan	17	suppressed
Cephalexin	Cephalexin	16	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Glipizide	Glipizide	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Divalproex Sodium	Divalproex Sodium	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Nystatin	Nystatin	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	14	suppressed
Carbamazepine	Carbamazepine	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Imipramine Hcl	Imipramine Hcl	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Meloxicam	Meloxicam	14	suppressed
Novofine Autocover	Pen Needle, Diabetic, Safety	14	suppressed
Primidone	Primidone	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Bethanechol Chloride	Bethanechol Chloride	13	suppressed
Dorzolamide-Timolol	Dorzolamide/Timolol/Pf	13	suppressed
Fentanyl	Fentanyl	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Atropine Sulfate	Atropine Sulfate	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	11
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error